Asthma Information Center
Cannabis Legalization Tied to Increases in Pediatric Asthma
Increases seen compared with states where neither recreational nor medical legalization has occurred.
Your search for asthma returned 849 results
Asthma Information Center
Fixed-Dose Combo Airsupra Approved as Rescue Therapy for Asthma
Airsupra is a first-in-class, pressurized metered dose inhaler, fixed-dose combination of albuterol and budesonide.
ACAAI 2022
Exacerbation Risk Exists for Patients With All Levels of Asthma Control/Severity
In patients using as-needed short-acting beta2-agonists, how are exacerbations associated with asthma control, maintenance adherence, and disease severity?
ACAAI 2022
Use of Biologics Reduces Exacerbations, Emergency Visits in Pediatric Asthma
A real-world study assessed how pediatric patients with moderate to severe asthma responded to the use dupilumab, mepolizumab, and omalizumab.
ACAAI 2022
Mepolizumab Shows Real-World Efficacy in Allergic and Non-Allergic Asthma
While mepolizumab has proven safe and effective for severe asthma, how has it performed in treating those with allergic vs non-allergic asthma?
ACAAI 2022
Allergen Exposure, Other Factors Predict Limited Airflow in Pediatric Asthma
What are the most significant predictors of airflow limitation in children 5 to 18 years of age with severe asthma?
ACAAI 2022
Safety of Lebrikizumab Similar to Placebo in Patients With Uncontrolled Asthma
Researchers analyzed pooled safety data from 3 clinical trials of lebrikizumab for uncontrolled asthma to determine the drug’s safety profile.
ACAAI 2022
Uncontrolled Asthma in Hispanic/Latino Patients Improved With Tezepelumab
A post hoc analysis of the PATHWAY and NAVIGATOR trials assessed efficacy of tezepelumab in Hispanic/Latino patients with severe, uncontrolled asthma.
ACAAI 2022
Maintenance and Reliever Digital System vs Standard Care Improves Asthma Control
Researchers evaluated asthma control in participants receiving maintenance and reliever digital system vs standard maintenance and reliever inhalers.
ACAAI 2022
Number of Patient-Reported Severe Asthma Triggers Predicts Morbidity
Which is a better predictor of morbidity in patients with severe asthma, blood eosinophil count or the number of patient-reported asthma triggers?
- Loading...
Loading...
Next post in ACAAI 2022
Loading... 
Loading...